Performance Review
-
Upload
muhammad-hossain -
Category
Documents
-
view
55 -
download
2
Transcript of Performance Review
PERFORMANCE REVIEW
Muhammad Tanvir Hossain – ID 4325352Fahima Rubayet Alam – ID 4466068Chukwumereze Udochi Unegbu – ID 2364171
Table of Contents
• C o m p a n y B a c k g r o u n d• Q u a l i t a ti v e R e v i e w• Q u a n ti t a ti v e R e v i e w• O b j e c ti v e s f o r fi n a l 3 r o u n d s• C o n c l u s i o n
I n t r o d u c ti o n
• Type of Company- Listed Public Limited ( Helsinki Stock Exchange)
• Company’s history
• Achievements
MISSION STATEMENT:“YOUR HEALTH OUR PRIORITY”
• To improve patients' lives by providing customers with innovative science and
differentiated healthcare solutions delivered by diverse and engaged talent with integrity,
passion and focus on performance.
V I S I O N
• Renata’s meaning- Born again;• At Renata, we're inspired by a single goal:
your health. That's why we're dedicated to developing new, safe medicines to prevent and treat the world's most serious diseases. And why we are making them available to the people who need them most. We believe that from progress comes hope and the promise of a healthier world.
SPECIFIC
•To achieve good sales volume, brand awareness and market share globally.
MEASURABLE
•Get a market share of 55% by 4th round, 60% by 5th round and by the 6th round we are focusing on keeping 60% market share globally.
ACHIEVABLE
•Increasing the quality of products i.e. by the use of Total Quality Management (TQM)
•By using market penetration pricing strategy.
•Investing more in promotions e.g. advertising, word of mouth, customer care.
RELEVANT
•Good feedback of market survey.
TIME DEFINED
•By the end of Round 6.
RENATA MANAGEMENT STRUCTURE
MD/CEO-TANVIR HUSSEIN
EXECUTIVE DIRECTOR(FINANCE & OPERATIONS)-UNEGBU CHUKWUMEREZE UDOCHI
EXECUTIVE DIRECTOR(SALES & MARKETING)-FAHIMA RUBAYET ALAM
Responsibilities
Sales Production Finance
Round 1: Muhammad Tanvir Hossain
Fahima Rubayet Alam Unegbu Chukwumereze Udochi
Round 2: Unegbu Chukwumereze Udochi
Muhammad Tanvir Hossain Fahima Rubayet Alam
Round 3: Fahima Rubayet Alam Unegbu Chukwumereze Udochi Muhammad Tanvir Hossain
Round 4: Muhammad Tanvir Hossain
Fahima Rubayet Alam Unegbu Chukwumereze Udochi
Round 5: Unegbu Chukwumereze Udochi
Muhammad Tanvir Hossain Fahima Rubayet Alam
Round 6: Fahima Rubayet Alam Unegbu Chukwumereze Udochi Muhammad Tanvir Hossain
DATE AGENDA&TOPIC TIME VENUEMon-23/7/2012 Market Outlook &Analysis 15.30-17.30 Room 2.04Tue-24/7/2012 Strategic discussion on
Production22.00-00 Skype
Wed-25/7/2012 Strategic discussion on Sales 20.00-22.00 Skype
Thu-26/7/2012 Strategic discussion on Finance 15.30-17.30 Room 2.04
Fri-27/7/2012 Weekly review & discussion on activities
15.30-17.30 Room 2.04
Sat-28/7/2012 Results review and discussion 19.00-21.00 SkypeMon-30/7/2012 Market Outlook &Analysis 16.00-18.00 Room 4.07Tues-31/7/12 Strategic discussion on Sales,
Finance and Production20.00-22.00 Skype
Fri-03/08/12 Weekly review & discussion on activities
11.00-15.00 Fahima's place
Sat-04/08/12 Results review and discussion 17.00-20.00 SkypeMon-06/08/12 Market Outlook &Analysis 14.00-17.00 Room 1.05Thurs-09/08/12 Strategic discussion on Sales,
Finance and Production11.00-14.00 Room 1.05
Fri-10/08/12 Weekly review & discussion on activities
17.00-19.30 Tanvir's place
Sat-11/08/12 Results review and discussion 19.00-21.00 SkypeMon-13/08/12 Market Outlook &Analysis 13.00-15.00 and 18.00-20.00 Room 1.05 and SkypeWedness-15/08/12 Strategic discussion on Sales,
Finance and Production17.00-20.00 Skype
Wedness-22/08/12 Weekly review & discussion on activities
10.00-13.00 Fahima's house
Thurs-23/08/12 Results review and discussion 11.00-13.00 Room-4.07Sat-25/08/12 Market Outlook &Analysis 11.00-14.00 Eze's houseTues-28/08/12 Strategic discussion on Sales,
Finance and Production18.00-21.00 Skype
Fri-31/08/12 Weekly review & discussion on activities
10.00-14.00 Room-2.05 and 2.11
Sat-01/09/12 Results review and discussion 17.00-19.00 SkypeMon-03/09/12 Market Outlook &Analysis 13.00-14.00 Room-1.05Thurs-06/09/12 Strategic discussion on Sales,
Finance and Production13.00-15.00 Room-2.07
Fri-07/09/12 Weekly review & discussion on activities
11.00-14.00 Tanvir's place
Sat Results review 18.00-20.00 Skype
RENATA LEADERSHIP STYLE •Democratic/Participative leadership
Executive Director CEO Executive
Director
•Joint decisions•Team effort•Working cohesively as a unit•CEO approves.
13
Tuckman and Jensen’s 5 Stages of Team Development
Forming Storming Norming Performing Adjourning
•Members are observant, shielded and distant•No set ground rules•Harmony and mutual aid
•Conflict in the group•Members opting out resulting in losing members •Resistance to perform as a group
•Personal relationships created•Ground rules are laid down and followed•Able to execute tasks
•Harmony among group members•Maximum focus on the tasks•Relationships are intensified
•Tasks are completed•Dissolution and mourning stage
Source: Cameron 2009: 256
14
The Team Performance Curve Katzenbach and Smith (1993)
Working Group Potential
Team
Real Team
High performance
Team
Pseudo Team
Team Effectiveness
Perf
orm
ance
Impa
ct
Designed by the author of this presentation using information from Katzenbach and Smith (1993)
C u l t u r a l d i ff e r e n c e s
• L a n g u a g e b a r r i e r• C o m m u n i c a ti o n p r o b l e m s• H i g h / l o w c o n t e x t p r o b l e m s
Using Fayol(1916) theory to address Time Management
• Forecasting • Planning• Organizing• Commanding• Coordinating• Controlling
Summary of PerformanceProduction:
Round One Round Two Round Three
Rubbana AndyOx Rubbana AndyOx Rubbana AndyOx
Finland 89.00 95.00 91.00 113.00 93.00 128.00
USA 63.88 74.87 74.00 90.00 85.00 101.00
S a l e s :Round One Round Two Round Three
Rubbana AndyOx Rubbana AndyOx Rubbana AndyOx
Finland 22.63 38.64 23.30 40.54 24.16 44.60
France 55.00 60.60 63.91 71.80 64.65 78.12
USA 65.63 78.87 69.19 84.33 74.85 94.11
P r o fi t
Round One Round Two Round Three0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
PharmateamRenata Ltd.Ecolab Pharma Ltd.
S u m m a r y o f p o s i ti o nCurrent market position:
Round One Round Two Round Three0
5
10
15
20
25
30
35
40
45
Pharmateam
Renata Ltd.
Ecolab Pharma Ltd.
PharmateamRenata Ltd.Ecolab Pharma Ltd.
• Investing more on R & D.• Market penetration pricing strategy.• Increasing the production as the demand rises • Less investment in machinery as it causes
more depreciation at the end of the year.• Increasing the wages of the employees so that
they are motivated to work more efficiently.
Qualitati ve review
Q u a n ti t a ti v e r e v i e w
• Minimizing gearing ratio to 10% by round 5.• Increase production by 10% to capture market
in round 4.• Reduce price by 2.5% by round 4 to achieve
target market share globally.• Reduce bid price to 245 (k EUR) and improve
selling effort to 70 (k EUR)
C o n c l u s i o n
• By using multichannel of marketing strategies Reneta would be able to lunch a brand new product.
• Our product will be offered in global market.• In France we have more than 60% market share.• We did not get biding past three round.• Investing more on production efficiency so we have
to pay less wages.• Reduce logistic cost delivery to France from Finland.
References
• Cesim, Practice Makes Profit. [Online] available from<http://sim.cesim.com/> [2012]
• Six Sigma performance. [Online] available from<http://www.bing.com/images/search?q=six+sigma+diagram&view=detail&id=2F960FF9C584FDCAAAB1257D9C4EEDADB53ACE02&FORM=IDFRIR> [10.08.12]
• Workplace Conflict Management. [Online] available from<http://www.mftrou.com/workplace-conflict-management-strategy.html> [2012]